Pharmacopeia and GlaxoSmithKline have entered a drug discovery and development alliance. Pharmacopeia and GSK–through its recently established Center of Excellence for External Drug Discovery (CEEDD)–will collaborate to deliver clinically validated therapeutic candidates to GSK’s global R&D organization. The goal of the alliance is for Pharmacopeia to discover active molecules and bring them to clinical proof of concept, yielding novel candidates in broad therapeutic a...